Aquatic Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,539
Closed -$5.43M 1385
2026
Q1
$5.43M Buy
+18,539
New +$6.09M 0.16% 173
2025
Q4
Sell
-35,982
Closed -$11.6M 1496
2025
Q3
$11.6M Buy
+35,982
New +$11.2M 0.22% 114
2024
Q1
Sell
-58,200
Closed -$27.4M 1322
2023
Q4
$27.4M Buy
58,200
+22,120
+61% +$10.2M 0.7% 28
2023
Q3
$15.7M Buy
36,080
+25,280
+234% +$11.5M 0.66% 40
2023
Q2
$4.8M Sell
10,800
-6,600
-38% -$3.04M 0.26% 93
2023
Q1
$8M Buy
+17,400
New +$8.28M 0.5% 54
2022
Q3
Sell
-5,300
Closed -$2.56M 1273
2022
Q2
$2.56M Buy
+5,300
New +$2.62M 0.83% 15

Other funds holding ELV

Aquatic Capital Management's ELV Position: Q2 2026 in Review

Aquatic Capital Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 18,539 shares — an estimated $5.43M sold.

Aquatic Capital Management first reported a position in ELV in Q2 2022 and held it in 7 quarters. The position peaked at $27.4M in Q4 2023. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Aquatic Capital Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 18,539 Elevance Health shares in Q2 2026, an estimated $5.43M.
  • Aquatic Capital Management first reported a position in Elevance Health in Q2 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Elevance Health position peaked at $27.4M in Q4 2023.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.